The DOI matches its Crossref record.
Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens.
Abstract
Studies on regional differences of adipose tissue metabolism have mainly been performed in vitro. To allow measurements of lipid uptake in vivo in man, radioactive label from [9,10-3H]oleic acid in 80 g orally administered milk fat was measured after 4 h in abdominal and femoral sc adipose tissues in 28 middle-aged, abdominally obese men. Radioactivity was measured in adipose tissue triglycerides extracted from needle biopsies. Lipoprotein lipase (LPL) activity was also measured. Uptake of label in triglycerides and LPL activity were higher (20% and 15%, respectively; P < 0.05) in the abdominal compared to the femoral adipose tissue region. The men were then randomly assigned to three groups, receiving testosterone (T), dihydrotestosterone, or placebo, for 9 months. After 2 months of treatment, the procedure of administration of label was repeated, this time using [U-14C]oleic acid as a marker. Measurements of radioactive label was then performed after 4 h and monthly up to 7 months. Supplementation with T was followed by an inhibited uptake of label in triglycerides (34%; P < 0.05), lower LPL activity (48%; P < 0.05), and a shorter t1/2 (30%; P < 0.05) in the abdominal adipose tissue region compared with the dihydrotestosterone and placebo groups. No significant effect of T on triglyceride uptake, LPL activity, or t1/2 was found in sc femoral adipose tissue. It was concluded that the turnover rate of depot triglycerides is more rapid in abdominal compared to femoral sc adipose tissue in men. Furthermore, T supplementation inhibits triglyceride uptake and LPL activity and causes a more rapid turnover of triglycerides only in the sc abdominal adipose tissue region. These results demonstrate the marked effects of T on adipose tissue metabolism in vivo and suggest that T is an important regulator of the proportion of depot fat mass in central and peripheral adipose tissue in men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Comprising 40-50% of lean body mass in normal weight adults, skeletal muscle is the most abundant organ in the body (148).”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [148]
In the citing paper
“Physiologically, skeletal muscle not only plays a significant role in maintaining posture, movement, and vital actions, skeletal muscle is also an integral regulator of whole-body metabolism as a central determinant of total daily energy expenditure and glucose homeostasis (148, 149).”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [148]
Citations
Cited by
Sorted by citations
Items 201–300 of 330
Zuo, Q., Park, N. H., Lee, J. K., Casiano, A. S., & Madak‐Erdogan, Z. (2023) · Steroids · doi:10.1016/j.steroids.2023.109330 · Cited by 23
Oxandrolone Augmentation of Resistance Training in Older Women
Mavros, Y., O’Neill, E. F., CONNERTY, M., Bean, J. F., Broe, K. E., Kiel, D. P., MacLean, D. B., TAYLOR, A., Fielding, R. A., & Singh, M. A. F. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000690 · Cited by 24
Bhasin, S., Bross, R., Storer, T. W., & Casaburi, R. H. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_7 · Cited by 23
Bessesen, D. H., Cox‐York, K. A., Hernandez, T. L., Erickson, C. B., Wang, H., Jackman, M. R., & Van Pelt, R. E. (2015) · Obesity · doi:10.1002/oby.20935 · Cited by 21
“The half-life of TG (net turnover) appears to be 50% longer in femoral compared to abdominal SAT (33,34).”
BackgroundTherapeutic potential of antisense oligonucleotides for the management of dyslipidemia
Carpentier, A. C., Labbé, S. M., Grenier–Larouche, T., & Noll, C. (2011) · Clinical Lipidology · doi:10.2217/clp.11.60 · Cited by 23
Venkatesh, V. S., Grossmann, M., Zajac, J. D., & Davey, R. A. (2022) · Obesity Reviews · doi:10.1111/obr.13429 · Cited by 22
“note, testosterone has been shown to downregulate lipoprotein lipase in abdominal subcutaneous tissue, which stimulates release of free fatty acids contributing to systemic insulin resistance.(92) In a controlled”
BackgroundCorrelation of sex hormone and androgen receptor with diabetes mellitus in elderly men
Cao, J., Li, J., Hao, W., Li, X., Wang, H., Liu, L., Zhu, B., & Guo, Z. (2011) · The Aging Male · doi:10.3109/13685538.2011.575479 · Cited by 21
“A high level of testosterone within the physiological range can inhibit lipoprotein lipase activity, reduce fat mass and increase muscle content, and thus improve insulin resistance [14].”
BackgroundLi, J., Lai, H. C., Chen, S., Zhu, H., & Lai, S. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.022 · Cited by 19
Dietary fatty acid metabolism in prediabetes
Noll, C., & Carpentier, A. C. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000369 · Cited by 20
Does Weekend Catch-up Sleep Affect High-Sensitivity C-Reactive Protein Levels Among Korean Workers?
Jung, S. W., Lee, K.-J., & Lee, J. (2019) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001657 · Cited by 19
Giannoulis, M. G., Jackson, N., Shojaee‐Moradie, F., Sönksen, P. H., Martin, F. C., & Umpleby, A. M. (2006) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.08.001 · Cited by 19
“GH and T may have important effects on VLDL metabolism through their lipolytic action on body fat [36,37], combined with an inhibitory effect of GH on lipoprotein lipase (LPL) which would increase the flux of free fatty acids (FFAs) to the liver [38].”
BackgroundNiesler, C. U., Prins, J. B., O’Rahilly, S., Siddle, K., & Montague, C. T. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801649 · Cited by 19
Sex Differences in Body Fat Distribution
Veilleux, A., & Tchernof, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0965-6_5 · Cited by 17
Age-Related Changes in the Male Reproductive System
Bhasin, S., Gagliano‐Jucá, T., Huang, G. T.-W., & Basaria, S. S. (2000) · Europe PMC (PubMed Central) · Cited by 18
Adipose organ dysfunction and type 2 diabetes: Role of nitric oxide
Bahadoran, Z., Mirmiran, P., & Ghasemi, A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116043 · Cited by 17
Aydoğdu, A., Bolu, E., Sönmez, A., Taşçı, İ., Haymana, C., Acar, R., Meriç, C., Taşlıpınar, A., Özgürtaş, T., & Azal, Ö. (2012) · Clinical Endocrinology · doi:10.1111/cen.12135 · Cited by 17
Hypogonadism in men with type 2 diabetes
Jones, T. H. (2007) · Practical Diabetes · doi:10.1002/pdi.1117 · Cited by 15
Visceral obesity, androgens and the risks of cardiovascular disease and diabetes mellitus
Gooren, L. J. (2001) · The Aging Male · doi:10.1080/tam.4.1.30.38 · Cited by 15
Androgen therapy in non-gonadal disease
Liu, P. Y., & Handelsman, D. J. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_17 · Cited by 15
Tao, J., Dai, W., Lyu, Y., Liu, H., Le, J., Sun, T., Yao, Q., Zhao, Z., Jiang, X., & Li, Y. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00599-1 · Cited by 14
“Testosteronetherapyinpatientswithobesityleads todecreasedTC,TG,andLDL-Clevels 35 .”
Testosterone and Atherosclerosis Progression in Men
Bhasin, S., & Herbst, K. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1929 · Cited by 14
Does low testosterone affect adaptive properties of adipose tissue in obese men?
Ruige, J. B. (2010) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2010.525239 · Cited by 14
Role of the Adipocyte in Metabolism and Endocrine Function
Ravussin, É., & Smith, S. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00036-6 · Cited by 16
Androgen Effect on Body Composition and Fat Metabolism
Jensen, M. D. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(19)30646-9 · Cited by 14
Watve, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4409-1_7 · Cited by 13
Saleh, J., Al‐Maqbali, M., & Abdel‐Hadi, D. (2019) · Comprehensive physiology · doi:10.1002/cphy.c170037 · Cited by 15
Prevalence of erectile dysfunction among Saudi type 2 diabetic patients.
Hassan, A., Aburisheh, K. H., Sheikh, T., Meo, S. A., Ahmed, N., & Sharqawi, A. (2014) · PubMed · Cited by 12
Effects of androgens in men with the metabolic syndrome
Mårin, P. (1998) · The Aging Male · doi:10.3109/13685539809148611 · Cited by 12
Self-citationDiagnosis of Male Infertility and Hypogonadism
Behre, H. M., Yeung, C., & Nieschlag, E. (1997) · Springer eBooks · doi:10.1007/978-3-662-03455-2_6 · Cited by 12
Lu, Y., Li, J., Cheng, X., Li, N., Miao, X., Sun, B., Yan, S., & Li, C. (2018) · The Aging Male · doi:10.1080/13685538.2018.1481940 · Cited by 11
Kalicińska, E., Wojtas, K., Majda, J., Zacharski, M., Skiba, J., Śliwowski, J., Banasiak, W., Ponikowski, P. P., & Jankowska, E. A. (2018) · The Aging Male · doi:10.1080/13685538.2018.1494144 · Cited by 11
“In fact, withdrawing of testosterone supplementation in patients with hypogonadotropic hypogonadism increases insulin resistance [39].”
BackgroundThe Relationships Between Testosterone, Body Composition, and Insulin Resistance
Volpi, E., Lieberman, S. A., Ferrer, D. M., Gilkison, C. R., Rasmussen, B. B., Nagamani, M., & Urban, R. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.429 · Cited by 11
Diagnostik der Infertilität und des Hypogonadismus
Behre, H. M., Yeung, C., Holstein, A. F., Weinbauer, G. F., Gassner, P., & Nieschlag, E. (2000) · Springer eBooks · doi:10.1007/978-3-662-05739-1_6 · Cited by 10
Ferrer, R., Pardina, E., Rossell, J., Baena‐Fustegueras, J. A., Lecube, A., Balibrea, J. M., Caubet, E., González, Ó., Vilallonga, R., Fort, J. M., et al. (2014) · Obesity · doi:10.1002/oby.20861 · Cited by 9
“However, this result did not correlate with LPL activity in these tissues (2).”
Testosterona sérica e doença cardiovascular em homens
de Sá, E. Q. C., de Sá, F. C. F., Guedes, A. D., & Verreschi, I. T. N. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800004 · Cited by 9
Androgen therapy in non-gonadal disease
Handelsman, D. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.018 · Cited by 9
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-388-7:191 · Cited by 13
Gender Differences Mirrored: Andro-Pause, a Palindromic Meno-Pause, or Just a Lean-Pause?
Maggi, M. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00993.x · Cited by 9
The effect of testosterone level on metabolic syndrome: a cross-sectional study
Gücenmez, S., Yildiz, P., Dönderici, Ö., & Serter, R. (2023) · HORMONES · doi:10.1007/s42000-023-00507-w · Cited by 8
The relationship between testosterone and metabolic syndrome
Kawano, H. (2010) · Hypertension Research · doi:10.1038/hr.2010.52 · Cited by 8
Luo, S., Zhu, H., Huang, H.-F., & Ding, G. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02069-5 · Cited by 7
“Meanwhile, testosterone can also increase lipolysis via β-adrenergic receptors [75] and fat-free mass [76].”
Can Serum Testosterone Be Used as a Marker of Overall Health?
Mederos, M. A., Bernie, A., Scovell, J. M., & Ramasamy, R. (2015) · PubMed Central · Cited by 7
Relationship between Testosterone Level, Serum Omentin-1 and Insulin Resistance in Obese Men
El-Kaream, S. A. A., Abdel-Monem, S. M., Khalil, M., & Mohassab, G. I. (2015) · American Journal of Biomedical Sciences · doi:10.5099/aj150300134 · Cited by 7
Crowther, N. J., & Ferris, W. F. (2010) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2010.10872241 · Cited by 6
Sex Hormone Binding Globulin Gene Polymorphism and Risk of Type2 Diabetes Mellitus in Egyptian Men
Tarhouny, S. A. E., Zakaria, S., Abdu-Allah, A. M., Hadhoud, K. M., Hanafi, M., & Nozha, O. M. A. (2015) · West Indian Medical Journal · doi:10.7727/wimj.2014.088 · Cited by 6
“Testosterone decreases insulin resistance by regulating mature adipocytes and myocytes, enhances catecholamine-induced lipolysis in vitro (23), and reduces lipoprotein lipase activity and triglyceride uptake in human abdominal adipose tissue in vivo (24).”
BackgroundEffects of testosterone replacement on glucose and lipid metabolism
Errazuriz, I., Dube, S., Basu, A., & Basu, R. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000061 · Cited by 6
Cannarella, R., Calogero, A. E., Condorelli, R. A., Aversa, A., & Vignera, S. L. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820966438 · Cited by 6
HORMONES AND SPORT Proof of the effect of testosterone on skeletal muscle
Bhasin, S., Woodhouse, L. J., & Storer, T. W. (2001) · Cited by 6
Testosterone, androgens and the risk of myocardial infarction
Crook, D. (1996) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1996.tb09522.x · Cited by 6
Hypogonadism and visceral obesity in men are full–fledged components of the metabolic syndrome
Troshina, E. A., & Terekhov, Р. A. (2023) · Obesity and metabolism · doi:10.14341/omet12980 · Cited by 5
Haider, A., Gooren, L. J., Padungtod, P., & Saad, F. (2009) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.002 · Cited by 5
“A study of testosterone administration restoring testosterone levels to mid-normal values with a duration of 8–9 months revealed a decrease in the visceral fat mass, a decrease in fasting glucose and lipid levels, and an improvement in insulin sensitivity; in addition, a decrease in diastolic blood pressure was observ…”
BackgroundVisceral obesity, the metabolic syndrome, androgens and estrogens
Gooren, L. J. (2006) · The Aging Male · doi:10.1080/13685530600659099 · Cited by 5
“A study of testosterone administration restoring testosterone levels to mid-normal values with a duration of 8–9 months [34] found a decrease of the visceral fat mass, a decrease of fasting glucose and lipid levels and an improvement of insulin sensitivity; in addition, a decrease in diastolic blood pressure was obser…”
BackgroundPostprandial triglyceride metabolism in elderly men with subnormal testosterone levels
Agledahl, I., Hansen, J., & Svartberg, J. B. (2008) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2008.00387.x · Cited by 5
Hypogonadism in Nigerian men with type 2 diabetes mellitus
Onung, S. I., Young, E. E., Ugwu, T. E., & Fasanmade, O. A. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0481-x · Cited by 5
Gooren, L. J. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.04.002 · Cited by 4
Phatak, S., Saboo, B., Dwivedi, S., Zinzuwadia, P., Panchal, D., Ganguli, A., & Hasnani, D. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_9_20 · Cited by 4
Johannsson, G., Mårin, P., Johansson, P., & Bengtsson, B. Å. (2000) · doi:10.1007/978-1-59259-015-5_15 · Cited by 4
Self-citationPathophysiology of Type 2 Diabetes
Kesavadev, J., Jawad, F., Deeb, A., Coetzee, A., Ansari, M., Shrestha, D., Somasundaram, N. P., & Kalra, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_8 · Cited by 3
Testosterone and Cardiovascular Disease in Men
de Sá, E. Q. C. (2013) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.1000142 · Cited by 3
“elevated concentrations in adipose tissue [45].”
BackgroundInfluentialGurudut, P. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i3.132 · Cited by 3
“(17) [Refer image 4] Here, the individual was made to lie in supine/ crook lying position.”
BackgroundTestosterone, the metabolic syndrome and diabetes mellitus
Heufelder, A. E. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.03.013 · Cited by 3
“…clinical study, testosterone has been demonstrated to inhibit triglyceride uptake and lipoprotein lipase activity, to cause a more rapid turnover of triglycerides in the subcutaneous abdominal adipose tissue as compared femoral fat and, perhaps, to mobilize lipids from the visceral fat depot [61].”
Role of testosterone and cortisol in metabolic syndrome and type 2 diabetes mellitus
Álvarez, A. Á., Suárez, R. M. G., Ramirez-Marrero, M. A., & Falcón (2010) · Revista cubana de endocrinología · Cited by 3
Han, H. J., Shin, J., Lee, C. B., Park, Y. S., Kim, D. S., Ahn, Y. H., Kim, T. W., & Choi, W. H. (2007) · The Korean Journal of Internal Medicine · Cited by 2
Testosterone Replacement Therapy in Men and Women
El‐Maouche, D., & Dobs, A. S. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00060-5 · Cited by 3
Lietuvos sveikatos mokslų universitetas
Šeškevičius, A., Lesauskaitė, V., Blaževičienė, A., Kubilius, R., Samėnienė, J., Gudas, R., & Macijauskienė, J. (2018) · Lithuanian University of Health Sciences · Cited by 3
The metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone
Cohen, P. (2009) · Andrologia · doi:10.1111/j.1439-0272.2009.00916.x · Cited by 3
“The decreased testosterone concentration then allows for the preferential deposition of abdominal/visceral fat (Marin et al., 1995), whereas the increased oestradiol production eventually leads to the feedback inhibition of LH.”
BackgroundCommentary: Androgen replacement therapy in the aging male--a critical evaluation.
Vermeulen, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · Cited by 3
Testosterone Supplementation and Aging-associated Sarcopenia
Bhasin, S. (2004) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-662-07019-2_12 · Cited by 2
Bidirectional Relationship Between Metabolic Syndrome and Erectile Dysfunction
Liu, W. (2011) · Urological Science · doi:10.1016/s1879-5226(11)60013-4 · Cited by 2
Soutelo, J., Samaniego, Y. A., Zotta, E., Fornari, M. C., Toso, C. R., & Ponzo, O. (2017) · International Journal of Endocrinology · doi:10.1155/2017/1623597 · Cited by 2
“Although the mechanism has not been completely clarified, it was stated that adipocytes express androgen receptor [38] and testosterone inhibit lipoprotein lipase (LPL) activity, responsible for the uptake of triglycerides by the adipocytes, and so producing an inhibition of the triglyceride uptake and a decrease of v…”
BackgroundKim, M., Yeo, Y., & Song, Y. (2022) · Korean Journal of Family Medicine · doi:10.4082/kjfm.21.0204 · Cited by 2
Mechanisms and Treatment of Obesity in Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_14 · Cited by 2
“In obese males, administration of testosterone is followed by a reduction in lipoprotein lipase (LPL) activity (that regulates lipogenesis) and free fatty acid (FFA) uptake in abdominal but not in subcutaneous adipose tissue ( 28 ).”
BackgroundWatve, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4409-1_11 · Cited by 2
Aji, A. S., Rohana, A. J., Alvitananda, A. A., Rachmah, Q., Paramashanti, B. A., Sulistyoningrum, D. C., & Pramono, A. (2026) · Discover Food · doi:10.1007/s44187-025-00782-z · Cited by 1
“This decreases triglyceride uptake in central fat storage and promotes insulin resistance [34, 35].”
Björntorp, P. A. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-59651-3_5 · Cited by 1
Self-citationAndrogens, visceral obesity and the risks for cardiovascular disease and diabetes mellitus
Gooren, L. J. (2007) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2007.02.001 · Cited by 1
Can the administration of testosterone to men with late-onset hypogonadism be discontinued?
Gooren, L. J. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.09.005 · Cited by 1
“A study of testosterone administration restoring testosterone levels to mid-normal values over a duration of 8–9 months [47] found a decrease in the visceral fat mass, a decrease in fasting glucose and lipid levels and an improvement in insulin sensitivity.”
(2019) · doi:10.31038/edmj.2019332 · Cited by 1
“Researchers have reported a dose dependent relationship between fructose ingestion and serum uric acid levels in both men and women, although in another study this relationship was confirmed only in men [45] It has been proved that fructose administration to normal rats for different time periods sequentially induces…”
BackgroundSíndrome metabólico y su relación con hipogonadismo tardío
Araya, A. V. (2014) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(14)70011-2 · Cited by 1
Interrelationship between Androgen Levels, Ageing, and Cognitive Functions
Joshi, H., & Parle, M. (2006) · Bioline International (Bioline International) · Cited by 1
[Action of androgens on fat distribution and metabolic balance].
Tostain, J.-B., Heim, M., & Rossi, D. (2004) · PubMed · Cited by 1
Ali, S., & Massa, M. G. (2021) · Journal of Student Research · doi:10.47611/jsr.v10i3.1337 · Cited by 1
“Thus, men with high levels of visceral fat tend to have low levels of testosterone compared to men with normal levels of visceral fat (Marin et al., 1995).”
BackgroundMale hypogonadism and pre-diabetes interplay: association or causal interaction? A systematic review
Greco, C., Corleto, R., Ebert, R., Simoni, M., Rochira, V., & Santi, D. (2021) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.14 · Cited by 1
Fadeeva, M. I., & Savelieva, L. V. (2014) · Obesity and metabolism · doi:10.14341/omet2014142-47 · Cited by 1
Shadid, S. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20070523ss · Cited by 1
The HAART-Induced Metabolic Syndrome
Tsiodras, S., Kelesidis, T., & Mantzoros, C. S. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_23 · Cited by 1
Perelló, M., Castrogiovanni, D. C., Moreno, G., Gaillard, R. C., & Spinedi, E. (2003) · PubMed · Cited by 20
Cunningham, G. R., & Hirshkowitz, M. (1997) · Springer eBooks · doi:10.1007/978-1-4612-1848-7_24 · Cited by 1
Role of the Adipocyte in Metabolism and Endocrine Function
Ravussin, É., & Smith, S. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00037-x · Cited by 1
Bhasin, S., Woodhouse, L. J., & Storer, T. W. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_20 · Cited by 1
Hypogonadism in Men With HIV-AIDS
Bhasin, S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-727-7_11
Böttner, A., Kratzsch, J., Beck‐Sickinger, A. G., Stümvoll, M., & Kieß, W. (2006) · Springer eBooks · doi:10.1007/3-540-28782-5_18
Henry, R. R., Phillips, S. A., Mudaliar, S. R. D., & Ciaraldi, T. P. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05006-x
Hypoandrogen–metabolic (HAM) syndrome: an important men's health issue
Gould, D. C. (2007) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2007.03.007
“In addition to inhibiting adipogenic differentiation, testosterone also reduces the uptake of triglycerides into adipocytes by inhibiting lipoprotein lipase [26].”
Blood Rheology, Sex Hormones, and Cortisol in Athletes
Melnikov, А. А., & Викулов, А. Д. (2004) · Human Physiology · doi:10.1023/b:hump.0000042619.36197.d5
“Testosterone also inhibits both utilization of circulating TG [33] and lipoprotein lipase in adipose tissue [30].”
BackgroundAndrogen Deficiency in Men Without Overt Pituitary-Gonadal Disease: The Role of Testosterone Therapy
Bhasin, S. (2000) · Endocrine updates · doi:10.1007/978-1-4757-6507-6_6
Testosterone and Its Association with Metabolic and Cardiovascular Disease
Corona, G., Rastrelli, G., & Maggi, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-179-0_5
Der Link zwischen erektiler Dysfunktion und metabolischem Syndrom - Möglichkeiten der Behandlung
Yassin, A. A., & Saad, F. (2008) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Review Testosterone and Erectile Dysfunction
Yassin, A. A., Saad, F., & Schering, B. (2008)
Síndrome metabólico y su relación con hipogonadismo tardío
Verónica Araya, Q. (2014) · Revista Médica Clínica Las Condes
Metadata
- Authors
- Mårin, P., Odén, B., & Björntorp, P.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1995-01
- Volume
- 80
- Issue
- 1
- Pages
- 239-243
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2129627391
- Cited by
- 332
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 11 · 2015: 10 · 2014: 10 · 2013: 10 · 2012: 11
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- triglyceride uptake, adipose tissue metabolism, abdominal fat, subcutaneous adipose tissue, androgens, testosterone, dihydrotestosterone, lipoprotein lipase, triglyceride turnover, abdominal obesity
- MeSH terms
- Abdomen, Adipose Tissue, Adult, Femur, Humans, Lipoprotein Lipase, Male, Middle Aged, Skin, Dihydrotestosterone, Testosterone, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
